Thomas Woiwode's Net Worth

$1.07 Million

Estimate Recalculated Nov 1, 2024 09:19AM EST

Who is Thomas Woiwode?

Thomas Woiwode has an estimated net worth of $1.07 Million. This is based on reported shares across multiple companies, which include Gritstone Oncology, Inc., CRISPR Therapeutics AG, Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., Millendo Therapeutics, Inc., Passage BIO, Inc., and Audentes Therapeutics, Inc..

SEC CIK

Thomas Woiwode's CIK is 0001619294

Past Insider Trading and Trends

2021 was Thomas Woiwode's most active year for acquiring shares with 8 total transactions. Thomas Woiwode's most active month to acquire stocks was the month of May. 2017 was Thomas Woiwode's most active year for disposing of shares, totalling 3 transactions. Thomas Woiwode's most active month to dispose stocks was the month of October. 2019 saw Thomas Woiwode paying a total of $0.00 for 53,570 shares, this is the most they've acquired in one year. In 2018 Thomas Woiwode cashed out on 1,653 shares for a total of $85,046.85, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gritstone Oncology, Inc. (GRTS) Snapshot price: $0.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-32.99%
-444.62K
—
—
903.09K
Scheduled
Aug 25
Form 4
∞
1.35M
$3.71
$5,000,000.39
1.35M
Dec 30
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 19
Form 4
∞
3.1M
—
—
3.1M
Oct 2
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
-6.43%
-44.00K
$57.99
-$2,551,440.00
640.01K
May 15
Form 4
-4.26%
-121.36K
$50.86
-$6,115,872.59
2.73M
Scheduled
May 7 - May 8
Form 4
-2.03%
-30.57K
$50.28
-$1,537,137.92
1.48M
Scheduled
Apr 30
Form 4
-6.84%
-222.26K
$50.08
-$11,136,437.01
3.03M
Scheduled
Apr 26 - Apr 27
Form 4
-1.30%
-22.84K
$50.90
-$1,164,655.40
1.73M
Scheduled
Apr 24
Form 4
-13.00%
-599.67K
$50.83
-$5,168,901.34
4.01M
Scheduled
Apr 20 - Apr 23
Form 4
-38.15%
-3.06K
$20.29
-$62,070.47
4.96K
Scheduled
Dec 22
Form 4
-19.16%
-1.90K
$20.21
-$38,405.85
8.02K
Scheduled
Nov 24 - Nov 27
Form 4
-33.19%
-2.29M
—
—
4.62M
Sep 5
Form 4
—
0
—
—
0
May 31
Form 4
+2,783.12%
6.67M
$14.00
—
6.91M
Oct 18 - Oct 24
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found

Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 12
Form 4
+211.67%
12.78K
—
—
18.82K
Dec 14
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
May 31
Form 4
+47.69%
22.73K
—
—
70.38K
Jun 12
Form 4
+4.89%
2.22K
—
—
47.65K
Apr 28
Form 4
+8.88%
3.7K
—
—
45.43K
Mar 31
Form 4
+9.94%
3.77K
—
—
41.73K
Feb 28
Form 4
+10.00%
3.45K
—
—
37.95K
Jan 31
Form 4
+11.11%
3.45K
—
—
34.5K
Dec 30
Form 4
+12.74%
3.51K
—
—
31.05K
Nov 30
Form 4
+14.03%
3.39K
—
—
27.55K
Oct 31
Form 4
∞
24.16K
—
—
24.16K
May 11
Form 3
—
0
—
—
0
No matching records found

Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 17
Form 4
-24.86%
-483.75K
—
—
1.46M
Scheduled
Jun 11
Form 4
-19.91%
-483.75K
—
—
1.95M
Scheduled
Apr 26
Form 4
∞
3.29M
$15.00
—
3.29M
Oct 20
Form 3
—
0
—
—
0
No matching records found

Millendo Therapeutics, Inc. (TPST) Snapshot price: $1.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
∞
2.12M
$2.36
$4,999,999.84
2.12M
Apr 29
Form 4/A
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
∞
2.18M
—
—
2.18M
Jun 25
Form 3
—
0
—
—
0
No matching records found